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Abstract Disulfide bonds occurred in majority of secre-
ted protein. Formation of correct disulfide bonds are must
for achieving native conformation, solubility and activity.
Production of recombinant proteins containing disulfide
bond for therapeutic, diagnostic and various other purposes
is a challenging task of research. Production of such pro-
teins in the reducing cytosolic compartment of E. coli
usually ends up in inclusion bodies formation. Refolding of
inclusion bodies can be difficult, time and labor consuming
and uneconomical. Translocation of these proteins into the
oxidative periplasmic compartment provides correct envi-
ronment to undergo proper disulfide bonds formation and
thus achieving native conformation. However, not all
proteins can be efficiently translocated to the periplasm
with the help of bacterial signal peptides. Therefore, fusion
to a small well-folded and stable periplasmic protein is
more promising for periplasmic production of disulfide
bonded proteins. In the past decades, several full-length
proteins or domains were used for enhancing translocation
and solubility. Here, protein fusion tags that significantly
increase the yields of target proteins in the periplasmic
space are reviewed.
Keywords Fusion protein  Periplasmic space  Protein
folding  Solubility enhancer
Introduction
Since the advent of production of recombinant proteins,
application of therapeutic and diagnostic proteins as bio-
pharmaceuticals was changed remarkably (Walsh 2014).
These proteins are required in huge amount and usually can
not be obtained from natural sources due to extremely low
availability. Moreover, Genetically engineered proteins
with special benefits (e.g. Insulin analogs) are as such
molecules which can therefore only be obtained via
recombinant technology (Walsh 2000, 2006; Sanchez and
Demain 2012). Escherichia coli was the first and still
popularly used host for the fast and economical production
of recombinant proteins (Vincentelli and Romier 2013;
Chance et al. 1981; Choi and Lee 2004; Rosano and
Ceccarelli 2014; Lebendiker and Danieli 2014). In-depth
knowledge of genetic and biochemical pathways of E. coli
and availability of variety of vectors made is an attractive
host for such purposes. Although significant improvements
have been made at transcription, translation and translo-
cation, still obtaining soluble and bioactive proteins is a
major challenge (Pines and Inouye 1999; Baneyx 1999;
Rosano and Ceccarelli 2014).
Secreted proteins such as antibodies, enzymes, hor-
mones etc. are used for therapeutic and diagnostic appli-
cations. Secreted proteins having two or more cysteines
makes disulfide bonds, which is usually vital for structure
formation and bioactivity (Creighton 1997b; Creighton
et al. 1995; Clarke and Fersht 1993). The cytosol of
E. coli is reducing which gives inclusion bodies when
such proteins are expressed in the cytosol (Freedman
1989; Hwang et al. 1992; Aslund et al. 1994; Carmel-
Harel and Storz 2000; Russel 1995; Messens and Collet
2006). Usually in vitro oxidative refolding is difficult,
laborious, time consuming and may be uneconomical
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depending upon refolding yield (Lilie et al. 1998; Lange
and Rudolph 2009; Yamaguchi et al. 2013; Basu et al.
2011). Translocation of these proteins into the E. coli
periplasm provides favorable environment for oxidative
folding due to the presence of disulfide bond folding and
isomerization machinery (Gopal and Kumar 2013; Yoon
et al. 2010; Choi and Lee 2004). Moreover, proteases are
less abundant in periplasm and also its relatively less
crowded than cytosol which reduces the chances of pro-
teolysis and ease in the purification of recombinant pro-
teins (Makrides 1996). To secrete proteins into
periplasmic space, a translocation signal sequence must be
fused at the N terminus of proteins, but only the fusion of
signal sequence is not enough for efficient protein
translocation (Fekkes and Driessen 1999; Muller et al.
2001). The sequences on mature protein next to the signal
peptidase cut site and other parts of mature protein play
an important role in the secretion (Lee et al. 1989; Malik
et al. 2006). Under such condition, fusion to a full-length
periplasmic protein that is well stable, soluble and prop-
erly folded is more promising (Table 1).
Over two decades of extensive in vivo and in vitro
research on protein fusions constructs concluded that
fusion tags usually increases the yield and solubility of
their fusion partners (Costa et al. 2014; Waugh 2005).
Despite all these advancement, still it is difficult to choose
the best fusion system for a given protein of interest. In
general, selection of fusion tag depends upon the properties
of protein of interest itself such as size, stability, and
hydrophobicity; the expression site; and the usage of the
recombinant protein. After coupling with second protein
(fusion tag) the increase in yield and solubility the target
proteins varies in each fusions. The detailed mechanism by
which fusion proteins improve solubility and yield is not
well understood. There is two hypotheses: (a) fusion of a
stable or conserved structure to an insoluble recombinant
protein may serve to stabilize and promote proper folding
of the recombinant protein (Butt et al. 2005) and (b) fusion
tags may act as a nucleus of folding ‘‘molten globule
hypothesis’’ (Creighton 1997a).
Ideally, an effective periplasmic fusion system should
have the following features: (a) efficient translocator;
(b) enhance folding and solubility; (c) help in purification;
(d) facilitate quantification; (e) minimize proteolysis; (f) no
adverse effect on the structure and bioactivity; (g) easy and
specific removal of the fusion tag; (h) useful for different
classes of proteins and peptides. However, none of the
fusion tag is optimal with respect to all of these parameters.
Successful examples of each periplasmic fusion proteins
are listed in Table 2. In the following sections, merits and
demerits of available periplasmic fusion proteins are
discussed.
Ecotin
Ecotin (E. coli trypsin inhibitor) is a homodimeric protein
which is naturally localized in the periplasmic space
(Table 1). The properties of ecotin make it a promising
periplasmic fusion tag. It is moderately small in size
(16 kDa monomer), extremely stable (tolerates pH 1.0 and
100 C for 30 min) and contains one disulfide bond in each
subunit (Chung et al. 1983). Due to the presence of
disulfide bonds, ecotin undergoes a pathway of oxidative
folding.
Naturally, ecotin is constitutively expressed (Chung
et al. 1983) for the defense of E. coli against trypsin like
serine proteases in the digestive tract and neutrophil elas-
tase like serine proteases in the blood. Ecotin had no
metabolic role or interaction with other proteins in E. coli
(Eggers et al. 2004). The C termini of each monomer in
dimeric ecotin protrude in opposite directions (Fig. 1a),
which will allow folding of passenger proteins at each end
without steric hindrance. Strong affinity of ecotin’s for
trypsin like serine protease will facilitate ecotin fusion
protein to purify via affinity chromatography. Ecotin’s
binding surface has been already randomized (Stoop and
Table 1 Properties of periplasmic fusion proteins
Fusion protein MW (kDa) calc. pI S–S bond Subcellular location
Ecotin 16 5.94 1 Periplasm
Maltose-binding protein 40.7 5.07 0 Periplasm
Z-domain of protein A 6.6 5.16 0 Secreted
ABD-domain of protein G 6 4.46 0 Secreted
CBD from exonuclease 11.1 8.44 1 Secreted
CBD from endonuclease 10.9 6.07 1 Secreted
Disulfide bond oxidoreductase 21.1 5.42 1 Periplasm
Barnase 12.3 8.88 0 Secreted
Size, calculated isoelectric point, number of disulfide bond and native localization were evaluated
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Craik 2003) to reduce its affinity to zymogens of serine
proteases, which would help to elute ecotin fusion proteins
under softer conditions.
Moreover, model protein in the ecotin fusion system can
be quantatively measured in a very sensitive trypsin inhi-
bition assays (Kang et al. 2005). Even in the cytosol ecotin
is stable and active; which makes it suitable candidate to be
used as cytoplasmic fusion tag (Kang et al. 2005). Ecotin
can also be produced in monomeric native state after
removal of the last 10 residues (Pal et al. 1996) Thus,
ecotin fusion protein in monomeric state is feasible. Ecotin
fusion tag have been used for efficient translocation, sol-
ubility enhancement and purification of proteins and pep-
tides (Paal et al. 2009; Malik et al. 2006, 2007).
Maltose-binding protein
Maltose-binding protein (MBP) is cysteine-less relatively
large (40.6 kDa) periplasmic protein (Fig. 1b) (Duplay
et al. 1984). It is known for its noteworthy solubility
enhancement when it is fused at the N terminus of model
proteins (Raran-Kurussi et al. 2015; Raran-Kurussi and
Waugh 2012; Sachdev and Chirgwin 1998). MBP has been
frequently utilized for cytosolic expression but due to its
natural periplasmic localization, it is also utilized as
periplasmic fusion tag for enhancing secretion, solubility as
well as purification of target proteins (Salema and Fer-
nandez 2013; Planson et al. 2003). In certain cases, it was
found that MBP attains natively folded state and remains
soluble while the passenger proteins could not attained
properly folded state and exist as in the state of soluble
aggregates (Nallamsetty et al. 2005; Nomine et al. 2001;
Sachdev and Chirgwin 1999). The affinity of MBP for
maltose is *1 lM which allowed to purify MBP fusion
protein through affinity chromatography (Betton and Hof-
nung 1996). Moreover, MBP is thermodynamically mod-
erately stable with the Tm of 62.8 C at pH 8.3
(Novokhatny and Ingham 1997) and individual compo-
nents of MBP fusions are slightly more stable than their
counterparts in the fusion protein (Blondel et al. 1996).
Staphylococcal protein A
Staphylococcal protein A (SpA) is a surface protein of
Gram-positive bacterium Staphylococcus aureus which
has strong affinity and high specificity for constant (Fc)
part of human immunoglobulins as well as large number
of other animals (Eliasson et al. 1988; Cedergren et al.
1993). SpA is a highly soluble 31 kDa protein. Chemi-
cally denatured SpA renatures efficiently which assists
refolding of the target protein in the SpA fusion system
(Samuelsson et al. 1991). SpA is a cysteine-less protein,
thus abolishing the chances of interference in disulfide
bond formation with fused protein of interest (Kashimura
et al. 2013; Uhlen et al. 1984). The gene of SpA is
highly repetitive which consists of signal sequence fol-
lowed by five small highly similar domains (E, D, A, B
and C) and C terminal membrane anchoring sequence.
Table 2 Examples of protein
fusion tag assisted production of
recombinant proteins in the
periplasmic space of E. coli
Fusion protein Model protein References
Ecotin Pepsinogen Malik et al. (2006)
Ecotin Proinsulin Malik et al. (2007)
Ecotin Octapeptide Paal et al. (2009)
MBP Merozoite surface protein I Planson et al. (2003)
MBP Nanobodies (singe domain antibody) Salema and Fernandez (2013)
MBP Membrane protein U24 Tait and Straus (2011)
MBP Single chain antibody Hayhurst (2000)
MBP Pokeweed antiviral protein Honjo and Watanabe (1999)
SpA Insulin like growth factor-II Hammarberg et al. (1989)
SpA Alkaline phosphatase Engel et al. (1992)
SpG Insulin like growth factor-II Hammarberg et al. (1989)
SpG Octapeptide Stahl et al. (1989)
CBD Polypeptide Hasenwinkle et al. (1997)
CBD Lipase Hwang et al. (2004)
CBD Beta-glucosidase Ong et al. (1991)
CBD Alkaline phosphatase Greenwood et al. (1989)
DsbA Enterokinase catalytic subunit Collinsracie et al. (1995)
DsbA Proinsulin Winter et al. (2000)
Barnase Cystein knot peptide Schmoldt et al. (2005)
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The B-domain has been engineered to create smaller
variants (7 kDa) of SpA, called as Z-domain (Nilsson
et al. 1987). Depending upon localization requirements
of the target protein, large number of expression plas-
mids with or without signal sequences for the production
of single Z-domain (7 kDa) or double Z-domains
(14 kDa) fusions (Fig. 1c) has been developed (Nilsson
et al. 1994, 1996; Hammarberg et al. 1989; Stahl et al.
1989). The fusion protein with Z-domain was more
efficiently translocated in comparison to full length SpA
proteins (Nilsson et al. 1997).
Streptococcal protein G
Streptococcal protein G (SpG) present on the streptococci
surface is a bifunctional receptor and capable of binding
with both IgG and serum albumin from different species
with different affinities (Nygren et al. 1988). The IgG and
albumin binding regions are structurally separated on the
SpG. The serum albumin binding region is known as ABD
(albumin-binding domain), consists of three binding motifs
(each *5 kDa) (Fig. 1d). Depending upon the localization
of the target proteins, ABD with or without signal sequence
has been used for expression of fusion protein. Subse-
quently, fusion proteins were purified via HSA-affinity
chromatography in one-step (Hammarberg et al. 1989;
Larsson et al. 1996; Stahl et al. 1989).
Cellulose binding domain (CBD)
Nearly 111 residues from endoglucanase (Fig. 1e) and 100
residues from exoglucanase (Fig. 1f) of Cellulomonas fimi,
which has high affinity for cellulose, have been used for
translocation to periplasmic space and solubility enhance-
ment of target proteins (Gilkes et al. 1988, 1992; Warren
et al. 1986; Hwang et al. 2004; Hasenwinkle et al. 1997;
Creagh et al. 1996; Ong et al. 1991). The purification of
cellulose binding domain fusion protein was achieved via
relatively inexpensive ligand matrix (cellulose) (Green-
wood et al. 1989, 1992; Ong et al. 1991).
Disulfide bond oxidoreductase
Disulfide bond oxidoreductase (DsbA) is the key enzyme
of periplasmic oxidoreductive system (Fig. 1g). It facili-
tates correct disulfide bond formation via intra- and inter-
molecular catalysis (Bardwell et al. 1993). In
biotechnological applications, target proteins having mul-
tiple disulfide bonds (enterokinase catalytic subunit,
proinsulin) were fused at the C terminus of DsbA to
enhance disulfide bond formation as well as stabilize
unfolded target protein via its polypeptide binding site
(Collinsracie et al. 1995; Winter et al. 2000). After fusion
with DsbA, these proteins were obtained in the well-folded
soluble state in the periplasmic space. DsbA is a potent
protein thiol oxidase. It has been observed in vitro exper-
iments that DsbA causes non-native disulfide bond for-
mation in proteins having multiple disulfide bonds
(Hirudin, BPTI) (Wunderlich and Glockshuber 1993;
Zapun and Creighton 1994). Also, in vivo co-expression of
DsbA resulted in inclusion bodies formation of IGF-I (Joly
et al. 1998).
Barnase
Barnase is an enzymatically inactive variant (H102A) of
extracellular RNAse from Bacillus amyloliquefaciens
(Fig. 1h). It is monomeric, cysteine-less protein of rela-
tively small size. For biotechnological applications,
Fig. 1 Three-dimensional structure of periplasmic fusion proteins.
a ecotin (1ECZ), b Maltose binding protein (1DMB), c Z-domain of
protein A (1LP1), d ABD-domain of protein G (1EM7), e CBD of
endoglucanase (1EXG), f CBD of exoglucanase (modelled 3D
structure), g disulfide bond oxidoreductase (1A2J), h Barnase (1RNB)
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enzymatically inactive variant of RNAse was used as a
fusion protein to enhance the secretion of cysteine-knot
peptides in the periplasmic space. It was found that
majority of the cysteine-knot peptides were in the native
state when fused with barnase (Schmoldt et al. 2005).
Moreover, the Barnase fusion protein could be purified via
immobilized barstar (Barnase inhibitor) in single step
(Schmoldt et al. 2005).
Conclusion
Every protein is unique and due to their different applica-
tions such as academic research, diagnostic or therapeutic
usage, the quantity and purity level vary. Therefore, no
single fusion tag will address every requirement. Fusion
tags are helpful in enhancing their solubility and stability.
Protein fusion tag with lM-nM ligand affinity generally
results in 90–99 % purity after affinity chromatography.
Removal of protein fusion tag and producing recombinant
protein with authentic N terminal adds another layer of
complexity. When considering which protein fusion to use,
important queries should keep in mind such as: nature of
protein itself, how much protein required, application of
protein, is fusion tag removal necessary or not, how much
additional residues could be tolerated at N terminal? To
remove most part of the fusion protein, highly specific
protease cleavage site (TEV protease, thrombin, enteroki-
nase, etc.) could be placed in the linker region between
fusion tag and model protein. Also, non-specific proteases
such as trypsin could be used to generate authentic N ter-
minus as demonstrated in the case of Ecotin-proinsulin
fusion protein (Malik et al. 2007). If authentic N terminus
is must for the application, ubiquitin fusion technology
could be used as successfully demonstrated in ecotin–
ubiquitin–peptide fusion system (Paal et al. 2009).
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